...
首页> 外文期刊>Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research >White tea - A cost effective alternative to EGCG in fight against benzo(a) pyrene (BaP) induced lung toxicity in SD rats
【24h】

White tea - A cost effective alternative to EGCG in fight against benzo(a) pyrene (BaP) induced lung toxicity in SD rats

机译:白色茶 - 在SD大鼠抗苯唑(A)芘(A)芘(BAP)诱导肺部毒性的EGCG的成本效果替代

获取原文
获取原文并翻译 | 示例

摘要

Tea is a natural resource of catechins and exhibits antioxidative and anticancer activities. This study was designed to elucidate the comparative efficacy of white tea and pure EGCG in containing benzo (a) pyrene (BaP)-induced pulmonary stress. Rats were treated with white tea extract (WT) (1%) and pure EGCG at a dose of 80 mu g/ml in drinking water on alternate days for 12 weeks (4 weeks prior, during and after BaP treatment). BaP(50 mg/kg b. wt) was administered to rats orally in olive oil twice a week for four weeks. The indices such as stress biomarkers (LPO, PCC & ROS), antioxidant enzymes (SOD, CAT, GSH, GST, GR, GPx) activities and lung histoarchitecture were assessed. BaP administration enhanced the levels of inflammatory markers (NO and citrulline) and reduced activities of antioxidant enzymes. We observed similar antioxidant efficacy by both WT and EGCG as seen by their ameliorative action in restoring BaP induced oxidative and inflammatory stress as well as lung histoarchitecture. Our findings suggest that WT is equally beneficial as EGCG in maintaining the integrity of alveoli and is a potential candidate to be used as a cost effective and protective agent in conditions of BaP-induced lung damage.
机译:茶是儿茶素的自然资源,并展示抗氧化和抗癌活动。该研究旨在阐明白茶和纯EGCG在含苯佐(A)芘(BAP)的肺应激中的比较疗效。将大鼠用白色茶提取物(WT)(1%)(1%)(1%)(1%)和纯EGCG在饮用水中以80μg/ ml的饮用水剂的饮用水饮用的日子进行12周(在烘烤处理期间和之后4周)。烤(50mg / kg b.wt)在橄榄油口服两次向大鼠施用于橄榄油两次四周。评估了应激生物标志物(LPO,PCC&ROS),抗氧化酶(SOD,猫,GSH,GST,GR,GPX)活性和肺组织建筑等索引。 BAP管理增强了炎症标志物(NO和瓜氨酸)的水平,降低了抗氧化酶的活性。我们观察到WT和EGCG的类似抗氧化效果,如其改进的氧化和炎症应力以及肺组织结构所见的改进作用。我们的研究结果表明,WT同样有益于EGCG,以保持肺泡的完整性,并且是在BAP诱导的肺部损伤条件下用作成本效益和保护剂的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号